These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 27342787)

  • 1. Efficacy of echinocandins against murine infections by Diutina (Candida) rugosa.
    Sanchis M; Sutton DA; Wiederhold NP; Guarro J; Capilla J
    Diagn Microbiol Infect Dis; 2016 Sep; 86(1):61-5. PubMed ID: 27342787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antifungal therapies in murine infections by Candida kefyr.
    Sanchis M; Martin-Vicente A; Capilla J; Guarro J
    Mycoses; 2016 Apr; 59(4):253-258. PubMed ID: 26857550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamics of echinocandins against Candida glabrata: requirement for dosage escalation to achieve maximal antifungal activity in neutropenic hosts.
    Howard SJ; Livermore J; Sharp A; Goodwin J; Gregson L; Alastruey-Izquierdo A; Perlin DS; Warn PA; Hope WW
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4880-7. PubMed ID: 21807969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examination of the in vitro fungicidal activity of echinocandins against Candida lusitaniae by time-killing methods.
    Cantón E; Pemán J; Hervás D; Espinel-Ingroff A
    J Antimicrob Chemother; 2013 Apr; 68(4):864-8. PubMed ID: 23228935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo effects of echinocandins against Candida parapsilosis sensu stricto, Candida orthopsilosis and Candida metapsilosis.
    Spreghini E; Orlando F; Tavanti A; Senesi S; Giannini D; Manso E; Barchiesi F
    J Antimicrob Chemother; 2012 Sep; 67(9):2195-202. PubMed ID: 22635526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Killing Rates of Caspofungin in 50 Percent Serum Correlate with Caspofungin Efficacy Against Candida albicans in a Neutropenic Murine Model.
    Domán M; Kovács R; Kardos G; Gesztelyi R; Juhász B; Bozó A; Kardos T; Saleh Q; Majoros L
    Curr Drug Deliv; 2016; 13(2):255-64. PubMed ID: 27146910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential in vitro activity of anidulafungin, caspofungin and micafungin against Candida parapsilosis isolates recovered from a burn unit.
    Ghannoum MA; Chen A; Buhari M; Chandra J; Mukherjee PK; Baxa D; Golembieski A; Vazquez JA
    Clin Microbiol Infect; 2009 Mar; 15(3):274-9. PubMed ID: 19210699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of a single 6 mg/kg versus two 3 mg/kg caspofungin doses for treatment of disseminated candidiasis caused by Candida albicans in a neutropenic mouse model.
    Bayegan S; Szilágyi J; Kemény-Beke Á; Földi R; Kardos G; Gesztelyi R; Juhasz B; Adnan A; Majoros L
    J Chemother; 2011 Apr; 23(2):107-9. PubMed ID: 21571628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility to echinocandins of Candida spp. strains isolated in Italy assessed by European Committee for Antimicrobial Susceptibility Testing and Clinical Laboratory Standards Institute broth microdilution methods.
    Montagna MT; Lovero G; Coretti C; Martinelli D; De Giglio O; Iatta R; Balbino S; Rosato A; Caggiano G
    BMC Microbiol; 2015 May; 15():106. PubMed ID: 25990252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caspofungin in combination with amphotericin B against Candida glabrata.
    Barchiesi F; Spreghini E; Fothergill AW; Arzeni D; Greganti G; Giannini D; Rinaldi MG; Scalise G
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2546-9. PubMed ID: 15917570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of anidulafungin, caspofungin and fluconazole in the early phase of infection in a neutropenic murine invasive candidiasis model.
    Krishnan-Natesan S; Manavathu EK; Cutright JL; Chandrasekar PH
    Int J Antimicrob Agents; 2010 Jul; 36(1):33-6. PubMed ID: 20400270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro pharmacodynamics and in vivo efficacy of fluconazole, amphotericin B and caspofungin in a murine infection by Candida lusitaniae.
    Sandoval-Denis M; Pastor FJ; Capilla J; Sutton DA; Fothergill AW; Guarro J
    Int J Antimicrob Agents; 2014 Feb; 43(2):161-4. PubMed ID: 24360922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of caspofungin or anidulafungin with antimicrobial peptides results in potent synergistic killing of Candida albicans and Candida glabrata in vitro.
    Harris MR; Coote PJ
    Int J Antimicrob Agents; 2010 Apr; 35(4):347-56. PubMed ID: 20106636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in vivo dose-dependent activity of caspofungin and anidulafungin against echinocandin-susceptible and -resistant Aspergillus fumigatus.
    Lewis RE; Liao G; Hou J; Prince RA; Kontoyiannis DP
    J Antimicrob Chemother; 2011 Jun; 66(6):1324-31. PubMed ID: 21486855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of a Candida krusei isolate with reduced susceptibility to caspofungin during therapy.
    Hakki M; Staab JF; Marr KA
    Antimicrob Agents Chemother; 2006 Jul; 50(7):2522-4. PubMed ID: 16801435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo efficacy of anidulafungin and caspofungin against Candida glabrata and association with in vitro potency in the presence of sera.
    Wiederhold NP; Najvar LK; Bocanegra R; Molina D; Olivo M; Graybill JR
    Antimicrob Agents Chemother; 2007 May; 51(5):1616-20. PubMed ID: 17307976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fungicidal activity of anidulafungin in serum from patients does not correlate to its susceptible breakpoint against Candida spp.
    Stein GE; El-Mortada M; Smith C; Dybas L; Prince R; Havlichek D
    J Antimicrob Chemother; 2010 Feb; 65(2):374-6. PubMed ID: 19996140
    [No Abstract]   [Full Text] [Related]  

  • 18. Activity of aminocandin (IP960; HMR3270) compared with amphotericin B, itraconazole, caspofungin and micafungin in neutropenic murine models of disseminated infection caused by itraconazole-susceptible and -resistant strains of Aspergillus fumigatus.
    Warn PA; Sharp A; Morrissey G; Denning DW
    Int J Antimicrob Agents; 2010 Feb; 35(2):146-51. PubMed ID: 20015618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of anidulafungin's and fluconazole's in vivo activity in neutropenic and non-neutropenic models of invasive candidiasis.
    Wiederhold NP; Najvar LK; Bocanegra R; Kirkpatrick WR; Patterson TF
    Clin Microbiol Infect; 2012 Feb; 18(2):E20-3. PubMed ID: 22128831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the correlation of caspofungin MICs and treatment outcome in murine infections by wild type strains of Candida parapsilosis.
    Salas V; Pastor FJ; Capilla J; Sutton DA; Mayayo E; Fothergill AW; Rinaldi MG; Guarro J
    Diagn Microbiol Infect Dis; 2013 Sep; 77(1):41-5. PubMed ID: 23806662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.